Abiopharma

News list

Director Connaughton Bernadette 🔴 sold 1.6K shares of HALOZYME THERAPEUTICS, INC. (HALO) at $63.48 Transaction Date: May 01, 2026 | Filing ID: 000055

Full text

News bot May 5, 2026, 9:05 p.m.
🔍 Connaughton Bernadette (Director)

Company: HALOZYME THERAPEUTICS, INC. (HALO)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 1,625
Detailed Transactions and Holdings:
- Sold 1,625 shares of Common Stock at $63.48 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,498.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.